Table 1

Patient characteristics
Patient No./Age/Sex/Race*	*Diagnosis & Duration**	Time on drug^†	Concomitant medication^‡	Alcohol units/wk

1/46/M/WB	PsA 20 years	2 days (On re-challenge)	Piroxicam, temazepam, paracetamol and dextropropoxyphene.	8 units
2/35/F/WB	RA 3 months	14 days	Diclofenac, paracetamol and dextropropoxyphene.	None
3/35/M/BB	ReA ~3 months	31 days	Diclofenac, flucloxacillin, paracetamol with dihydrocodeine	8 units
4/50/M/WB	PsA 28 months	>270 days	Felodipine, lansoprazole.	>30 units
5/33/F/BB	RA 23 months	~14 days	Celecoxib	None
6/30/F/WB	RA <3 months	5 days	Diclofenac. Methylprednisolone 120 mg intra-muscularly before starting sufasalazine.	None
7/64/F/BB	RA 10 years	~12 days	Chlorpheniramine, lisinopril, aspirin, cetirizine. Inhaled steroids & β-agonists	None
8/37/F/BB	RA 7 months	~42 days	Rofecoxib, prednisolone, paracetamol with dihydrocodeine, aspirin, folic acid.	None
9/45/F/WB	?RA 6 months	~17 days	Sertraline	None
10/48/F/BB	RA 3 months	10 days	Lansoprazole, tramadol, stemetil, thyroxine, rofecoxib, co-proxamol	None

* WB – White British, BB – Black British of African or Carribean descent. PsA: Psoriatic arthritis. RA: rheumatoid arthritis. ReA: reactive arthritis. † For episode related to adverse event. ‡ At the time of adverse event.
Jobanputra et al. BMC Musculoskeletal Disorders 2008 9:48 doi:10.1186/1471-2474-9-48